2021 U.S.-Booked Air Volume: $10 million
Consolidated U.S. TMC: Amex GBT
Medical device manufacturer Boston Scientific generated $11.9 billion in net sales in 2021, an increase of 20 percent compared with 2020. It attributed the growth to enhanced digital capabilities and, as the pandemic eased, the launch of 145 new clinical trials and introduction of 90 new products. Despite this, the company’s 2021 U.S.-booked air travel spending dipped to $10 million from $12.5 million in 2020 and $50 million in 2019, according to BTN estimates.
The company hired more than 8,300 new employees in 2021, largely through remote working opportunities, and made five acquisitions, including the $1.75 billion takeover of Baylis Medical and $1.07 billion purchase of Lumenis’ global surgical business. Boston Scientific continued its buying spree into 2022, making two acquisitions from June to August 2022.